» Articles » PMID: 31591566

Axonal Iron Transport in the Brain Modulates Anxiety-related Behaviors

Overview
Journal Nat Chem Biol
Date 2019 Oct 9
PMID 31591566
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Iron is essential for a broad range of biochemical processes in the brain, but the mechanisms of iron metabolism in the brain remain elusive. Here we show that iron functionally translocates among brain regions along specific axonal projections. We identified two pathways for iron transport in the brain: a pathway from ventral hippocampus (vHip) to medial prefrontal cortex (mPFC) to substantia nigra; and a pathway from thalamus (Tha) to amygdala (AMG) to mPFC. While vHip-mPFC transport modulates anxiety-related behaviors, impairment of Tha-AMG-mPFC transport did not. Moreover, vHip-mPFC iron transport is necessary for the behavioral effects of diazepam, a well-known anxiolytic drug. By contrast, genetic or pharmacological promotion of vHip-mPFC transport produced anxiolytic-like effects and restored anxiety-like behaviors induced by repeated restraint stress. Taken together, these findings provide key insights into iron metabolism in the brain and identify the mechanisms underlying iron transport in the brain as a potential target for development of novel anxiety treatments.

Citing Articles

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


Elevated CXCL1 triggers dopaminergic neuronal loss in the substantia nigra of C57BL/6J mice: Evaluation of a novel Parkinsonian mouse model.

Ma X, Jia G, Li M, Zhang S, Wang Z, Song N Zool Res. 2025; 46(1):225-235.

PMID: 39846198 PMC: 11890994. DOI: 10.24272/j.issn.2095-8137.2024.228.


Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosis.

Khormi I, Fazlollahi A, Al-Iedani O, Vidyasagar R, Ayton S, Alshehri A Neuroradiol J. 2024; :19714009241303123.

PMID: 39631056 PMC: 11618841. DOI: 10.1177/19714009241303123.


Ablation of Iron Regulatory Protein 2 produces a neurological disorder characterized by motor, somatosensory, and executive dysfunction in mice.

Porras C, Olliviere H, Bradley S, Graham A, Chudasama Y, Rouault T Curr Res Neurobiol. 2024; 7:100136.

PMID: 39239479 PMC: 11372806. DOI: 10.1016/j.crneur.2024.100136.


Quantitative susceptibility mapping in the brain reflects spatial expression of genes involved in iron homeostasis and myelination.

Cohen Z, Lau L, Ahmed M, Jack C, Liu C Hum Brain Mapp. 2024; 45(9):e26688.

PMID: 38896001 PMC: 11187871. DOI: 10.1002/hbm.26688.


References
1.
Hentze M, Muckenthaler M, Galy B, Camaschella C . Two to tango: regulation of Mammalian iron metabolism. Cell. 2010; 142(1):24-38. DOI: 10.1016/j.cell.2010.06.028. View

2.
Crielaard B, Lammers T, Rivella S . Targeting iron metabolism in drug discovery and delivery. Nat Rev Drug Discov. 2017; 16(6):400-423. PMC: 5455971. DOI: 10.1038/nrd.2016.248. View

3.
Rouault T . Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci. 2013; 14(8):551-64. DOI: 10.1038/nrn3453. View

4.
Ward R, Zucca F, Duyn J, Crichton R, Zecca L . The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014; 13(10):1045-60. PMC: 5672917. DOI: 10.1016/S1474-4422(14)70117-6. View

5.
Zecca L, Youdim M, Riederer P, Connor J, Crichton R . Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004; 5(11):863-73. DOI: 10.1038/nrn1537. View